AFTATE ZINC OXIDE- zinc oxide ointment

Land: USA

Språk: engelska

Källa: NLM (National Library of Medicine)

Aktiva substanser:

ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z)

Tillgänglig från:

Sabel Med LLC

INN (International namn):

ZINC OXIDE

Sammansättning:

ZINC OXIDE 0.2 g in 1 g

Administreringssätt:

TOPICAL

Receptbelagda typ:

OTC DRUG

Bemyndigande status:

OTC monograph not final

Produktens egenskaper

AFTATE ZINC OXIDE- ZINC OXIDE OINTMENT
SABEL MED LLC
_Disclaimer: Most OTC drugs are not reviewed and approved by FDA,
however they may be marketed if they_
_comply with applicable regulations and policies. FDA has not
evaluated whether this product complies._
----------
ZINC OXIDE OINTMENT (1 OZ AND 2 OZ)
AFTATE ZINC OXIDE
zinc oxide ointment
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN OTC DRUG
ITE M CODE (SOURCE )
NDC:70 356 -326
ROUTE OF ADMINISTRATION
TOPICAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
ZINC O XIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z)
ZINC OXIDE
0 .2 g in 1 g
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
PARAFFIN (UNII: I9 O0 E3H2ZE)
MINERAL O IL (UNII: T5L8 T28 FGP)
CETO STEARYL ALCO HO L (UNII: 2DMT128 M1S)
CETETH-2 0 (UNII: I8 35H2IHHX)
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:70 356 -326 -0 2
56 g in 1 TUBE; Type 0 : No t a Co mbinatio n Pro duct
0 5/0 1/20 16
2
NDC:70 356 -326 -0 1
28 g in 1 TUBE; Type 0 : No t a Co mbinatio n Pro duct
0 5/0 1/20 16
Sabel Med LLC
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
OTC mo no graph no t final
pa rt348
0 5/0 1/20 16
LABELER -
Sabel Med LLC (091476000)
Revised: 4/2016